- VeChain price staircase advance currently projects a consolidation.
- VET has posted an increase of over 2,800% in one year.
- ToolChain allows users to build and deploy customizable solutions.
VeChain price is now at a record overbought condition based on the weekly Relative Strength Index (RSI). Based on the sizeable gain last week and the staircase format of the advance since the end of December, there is an above-average probability that VET will consolidate with a downward drift or a price grind like in early January. Look for inside days or weeks to evaluate timeliness for a new entry.
VeChain price reacting to the upward trajectory in exciting partnerships
A news roll that is the envy of any blockchain, VET has sealed exclusive collaborative partnerships, with the most notable being Salesforce and PricewaterhouseCoopers (PWC). In the case of PWC, VeChain is assisting the firm in integrating distributed ledger technology (DLT) into its operations. It is a testament to the dedication and hard work of the VeChain development team, and the offshoot has been an incredible rise in the price of the digital currency.
Since the sling-shot pattern on the weekly chart in late December 2020, VET’s rally has been defined by four significant weekly gains, ranging from 42% to 79%, followed by some form of consolidation. If the pattern continues, speculators should be prepared for some type of consolidation over the next week or two with price finding support at or around the 23.6% Fibonacci retracement of the rally from the cup-with-handle breakout in early January.
Critical to the long-term price outlook is the support at the 361.8% extension of the 2018-2020 bear market at $0.097 if the correction takes a deeper course. This level was resistance for three weeks in March and early April. A failure to provide support puts the 10-week simple moving average (SMA) at $0.082 in play. This moving average has been support on a closing basis beginning in mid-November 2020.
VET/USD weekly chart
It is tough to stand in front of a powerful trend. VET could break with the precedent since December and continue to rally much higher this week. If that scenario unfolds, traders should look to $0.166 as the next level of resistance, followed by $0.191.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.